KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Buildings: 2012

  • Arbutus Biopharma's Buildings was N/A to $6.0 million in Q4 2012 from the same period last year, while for Dec 2012 it was $6.0 million, marking a year-over-year change of. This contributed to the annual value of $6.0 million for FY2012, which is N/A change from last year.
  • Latest data reveals that Arbutus Biopharma reported Buildings of $6.0 million as of Q4 2012.
  • Over the past 5 years, Arbutus Biopharma's Buildings peaked at $6.0 million during Q4 2012, and registered a low of $6.0 million during Q4 2012.
  • Over the past 1 years, Arbutus Biopharma's median Buildings value was $6.0 million (recorded in 2012), while the average stood at $6.0 million.